IndraLab
Statements
reach
"For example, breast cancer 1 (BRCA1)/breast cancer 2 (BRCA2)-containing complex subunit 3 (BRCC3) deubiquitinates NLRP3, and pharmaceutical inhibition of DUBs restricts inflammasome activation [79,112,113], whereas E3 ubiquitin ligases LUBAC and TRIM33 promote inflammasome assembly [114,115]."
reach
"For example, breast cancer 1 (BRCA1)/breast cancer 2 (BRCA2) and containing complex subunit 3 (BRCC3) deubiquitinates NLRP3, and pharmaceutical inhibition of DUBs restricts inflammasome activation [XREF_BIBR, XREF_BIBR, XREF_BIBR], whereas E3 ubiquitin ligases LUBAC and TRIM33 promote inflammasome assembly [XREF_BIBR, XREF_BIBR]."
reach
"For instance, ubiquitination of NLRP3 by FBXL12, TRIM1, ARIH2 or the dopamine induced E3 ligase MARCH7 promotes the proteasomal degradation of NLRP3 in resting macrophages, whereas deubiquitylation of NLRP3 LRR domain on K63 by BRCC3 triggers ASC oligomerization and inflammasome activation (XREF_FIG)."